The Reflux Disease Questionnaire: a measure for assessment of treatment response in clinical trials.
about
Transoral Incisionless Fundoplication for Refractory Gastroesophageal Reflux Disease: Where Do We Stand?Measuring response in the gastrointestinal tract in systemic sclerosisValidation of the reflux symptom questionnaire electronic diary in partial responders to proton pump inhibitor therapy.Open access capture of patients with gastroesophageal reflux disease using an online patient-reported outcomes instrument.Systematic investigation of gastrointestinal diseases in China (SILC): validation of survey methodology.The Intestinal Gas Questionnaire: development of a new instrument for measuring gas-related symptoms and their impact on daily life.Validation and diagnostic usefulness of gastroesophageal reflux disease questionnaire in a primary care level in MexicoPrevalence of gastro-oesophageal reflux disease with upper gastrointestinal symptoms without heartburn and regurgitation.Online follow-up of individuals with gastroesophageal reflux disease using a patient-reported outcomes instrument: results of an observational study.Depression in primary TKA and higher medical comorbidities in revision TKA are associated with suboptimal subjective improvement in knee function.Structured management strategy based on the Gastro-oesophageal Reflux Disease (GERD) Questionnaire (GerdQ) vs. usual primary care for GERD: pooled analysis of five cluster-randomised European studiesSleep disturbance due to heartburn and regurgitation is common in patients with functional dyspepsia.Development of a Symptom-Based Patient-Reported Outcome Instrument for Functional Dyspepsia: A Preliminary Conceptual Model and an Evaluation of the Adequacy of Existing Instruments.Weight loss can lead to resolution of gastroesophageal reflux disease symptoms: a prospective intervention trialThe Effect of Zinc Supplementationon the Symptoms of Gastroesophageal Reflux Disease; a Randomized Clinical Trial.Is the reflux disease questionnaire useful for identifying GERD according to the Montreal definition?The impact of esophageal reflux-induced symptoms on quality of life after gastrectomy in patients with gastric cancer.Systematic review: ageing and gastro-oesophageal reflux disease symptoms, oesophageal function and reflux oesophagitis.Questionnaire based gastroesophageal reflux disease (GERD) assessment scales.Systematic review: symptom assessment using patient-reported outcomes in gastroesophageal reflux disease and dyspepsia.Development and validation of a patient-reported outcome instrument in partial responders to proton pump inhibitors.Randomised clinical trial: the burden of illness of uninvestigated dyspepsia before and after treatment with esomeprazole--results from the STARS II study.PRISM, a Patient-Reported Outcome Instrument, Accurately Measures Symptom Change in Refractory Gastroesophageal Reflux Disease.Psychometric evaluation of a daily gastro-oesophageal reflux disease symptom measure.The gain in quality-adjusted life months by switching to esomeprazole in those with continued reflux symptoms in primary care: EncomPASS--a cluster-randomized trial.Is the course of gastroesophageal reflux disease progressive? A 21-year follow-up.Phase 2b, randomized, double-blind 12-week studies of TZP-102, a ghrelin receptor agonist for diabetic gastroparesis.Long-term follow up in patients with gastroesophageal reflux disease with specific emphasis on reflux symptoms, use of anti-reflux medication and anti-reflux surgery outcome: a retrospective study.Normative values and factors affecting water-perfused esophageal high-resolution impedance manometry for a Chinese population.Hiatoplasty with Crura Buttressing versus Hiatoplasty Alone during Laparoscopic Sleeve Gastrectomy.Diagnosis of gastro-oesophageal reflux disease is enhanced by adding oesophageal histology and excluding epigastric pain.Randomised clinical trial: addition of alginate-antacid (Gaviscon Double Action) to proton pump inhibitor therapy in patients with breakthrough symptoms.A randomized, controlled, double-blinded and double-dummy trial of the effect of tongjiang granule on the nonerosive reflux disease of and Gan-Wei incoordination syndrome.Is gastroesophageal reflux disease associated with primary acquired nasolacrimal duct obstruction?Sustained benefit from intravenous immunoglobulin therapy for gastrointestinal involvement in systemic sclerosis.Study on the Therapeutic Effects of Drug and Cognitive-Behavioral Therapy on Non-Erosive Reflux Disease Patients With Emotional Disorders.Efficacy and Safety of Traditional Chinese Medicine on Nonerosive Reflux Disease: A Meta-Analysis of Randomized Controlled Trials.Development and Psychometric Assessment of a Self-evaluation Questionnaire for Gastroesophageal Reflux Disease
P2860
Q26766033-8EF13800-EC4A-490C-AC27-CD54FCC00147Q27022416-4A51F840-04EA-4B2B-9C44-F873744A3483Q30466802-1243B403-C05B-441D-83D4-FF6F922F888DQ30486107-B29F063D-D84A-41F3-9D3C-BF15FDC4473BQ30898909-755B81BC-1A28-4259-980E-0A24991DB5CDQ33464699-3A3A6E55-0BE6-43EA-8E16-2B7F660072F8Q34377203-C10D2C05-C71D-45C3-8E07-699EDAF84866Q34418706-00D965A9-39F7-4486-A474-904A1A8F1AE8Q35003385-AE1F13D4-D1DA-407B-AA43-7D6CE6082E72Q35146071-AF9B5247-A6C0-45B6-8756-D6DAB25792ACQ36695802-5BAB0D25-4A24-46CE-B5E6-D14A31E762BFQ36719837-E134086F-A15D-4DBC-9B40-5B72367B886DQ37253647-A56DA56A-CCBE-4227-9865-7A2963EAC380Q37368948-BA9A3686-E226-43AF-8333-DF3CD9294225Q37486223-0A852C81-9753-4C17-AAE8-322247B8E6D1Q37685322-83FD9671-1EC2-4CC0-AA41-B131F6544831Q37717702-FBADF95B-3ED1-4982-8802-1E8BC6F26DD6Q37817489-BB59B680-B267-4574-9B96-2C62CB3271DFQ37904827-24D0A5D5-AD6E-474E-A807-8EEA476FFB60Q38045930-20BD0217-082D-4908-AE2F-A767BADBC3C6Q38447198-1CD8F1CD-94CF-4345-B253-611524FD2E72Q38486082-3BE36DFD-006E-42B1-A72E-393C8F30319EQ39002955-FE75EBB0-C151-4C10-820F-056245047EBDQ39202658-FF0A8829-DD10-4FB4-AAE7-F917BD835889Q42675367-2D28CE70-6041-42E0-8F01-9F2D0D9229A2Q44458259-69D6A9F5-D80C-45EE-AF81-16F141CE8D3CQ44683655-489C861A-079B-4B47-9A0E-B2580F22B3FDQ46610233-60B3CA89-926F-4AD3-B8B0-8B29F9290925Q47566255-156C19ED-A191-43B4-8C8E-CADE22856E3DQ48090849-4DA8CEB4-9372-4800-A89C-B77FBE5534D4Q48104432-A3033928-E73E-4FF3-8479-3E03F7B14E10Q48206271-1E290961-4DDF-437A-8BB1-90D94288141DQ48663482-90A23777-6D90-4503-83CD-DDCBCAF317CAQ50079454-0AD89DB7-8285-4ED8-90CB-CC4F76C7C268Q53367668-BB2F1DBD-9D04-4E4E-9DA5-6A480A563881Q55114364-57C68F8D-5A68-4303-9246-5493B13EAB2FQ55427204-03B96D35-0196-4BBA-81AB-FEDE9551347EQ57819645-1E6F5F0C-A907-4C51-A521-77D8CEDE4DA4
P2860
The Reflux Disease Questionnaire: a measure for assessment of treatment response in clinical trials.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
The Reflux Disease Questionnai ...... t response in clinical trials.
@ast
The Reflux Disease Questionnai ...... t response in clinical trials.
@en
type
label
The Reflux Disease Questionnai ...... t response in clinical trials.
@ast
The Reflux Disease Questionnai ...... t response in clinical trials.
@en
prefLabel
The Reflux Disease Questionnai ...... t response in clinical trials.
@ast
The Reflux Disease Questionnai ...... t response in clinical trials.
@en
P2093
P2860
P356
P1476
The Reflux Disease Questionnai ...... t response in clinical trials.
@en
P2093
Folke Johnsson
Ingela Wiklund
Michael Shaw
Ola Junghard
Timothy Beebe
P2860
P2888
P356
10.1186/1477-7525-6-31
P577
2008-04-30T00:00:00Z
P5875
P6179
1021822886